New Immune-Boosting Innovation: Beyond the Vitamins and Minerals
Levagen® is a clinically studied form of palmitoylethanolamide (PEA).
Existing literature demonstrates PEA's ability to boost the immune system and provide symptomatic relief of flu symptoms.
This is done via numerous pathways, such as the activation of PPAR-a and inhibiting mast cell deregulation.
Learn more about PEA's immune-boosting mechanisms, make sure to download the Levagen+ Immune Health White Paper below.
Levagen+® is an innovative highly bioavailable form of palmitoylethanolamide (PEA).
Levagen® is also available in a cold water dispersible format, under Levagen+®. Levagen+® is powered by LipiSperse® technology, developed by award-winning Pharmako Biotechnologies, to increase functionality and bioavailability of PEA for food and beverage applications.
Levagen® is also self-affirmed GRAS, further substantiating its safety.
Levagen®: Human clinical trial for management of mild to moderate osteoarthritis symptoms*
Study Results: The effectiveness and safety of Levagen® has been recently studied in a double-blinded, randomized, placebo-controlled study. The clinical trial studied 120 patients with 40 patients on placebo, 40 patients on Levagen® 300 mg a day and 40 patients on Levagen® 600 mg a day. Both the 600 mg and the 300 mg doses were found to be statistically significant compared to the placebo on the total WOMAC score, pain subdomain, stiffness subdomain and function subdomain.*
Levagen+®: Double-blind Bioavailability Study
Study Results: A parallel, double-blind, bioavailability study was conducted with 28 healthy male and female volunteers over 18 years old to measure uptake of Levagen+® PEA over a 24-hour period. The objective of this trial was to determine whether the use of a lipid-based drug delivery system, LipiSperse®, can be successfully used to improve the bioavailability of Levagen®.
The Levagen+® formulation significantly increased plasma PEA concentration by approximately 1.8 times that of the standard PEA formulation*. The results indicate that by combining Levagen® with LipiSperse® delivery system, PEA absorption is more effective.*